Castle Biosciences Inc. (CSTL) has increased its revenue outlook for 2022, based on the first-quarter results. The company now anticipates total revenue in 2022 in the range of $118 million to $123 million, up from its prior outlook of $115 million to $120 million. Revenue was $94.1 million in 2021.
from RTT - Earnings https://ift.tt/E0l25Qe
via IFTTT
No comments:
Post a Comment